• Agenda
    • Get Involved
    • Attendee FAQs
    • Programs
    • In-Person Group Discussions
    • Short Courses
    • Plenary Keynotes
    • Speaker Biographies
    • Attendees
    • Networking
    • Archives
  • Sponsor/Exhibitor
    • Attendee Demographics + Event Features
    • Sponsorship Opportunities
    • Current Sponsors
    • Current Exhibitors - Floorplan
    • Re-sign Floorplan
    • Exhibit Services Schedule
    • Exhibitor Prospectus
    • Lead Generation Opportunities
    • FAQs
    • Sponsor & Exhibitor Portal
  • Media
    • Media Partners
    • Downloads
    • Media Gallery
  • Travel
  • Posters
    • Poster Information
    • Poster Titles
  • Register
    • Individual Pricing
    • Group Pricing
    • On Demand Pricing
Discovery on Target Mobile

Plenary Keynote Program

Join colleagues from around the world for the Discovery on Target Plenary Keynote Program. Bridging both halves of the event, it's the only time our whole community of drug discovery professionals assembles together to learn about big-picture perspectives, innovative technologies, and thought-provoking trends from luminaries in the field.


Outlook YouTube Facebook LinkedIn Twitter
#BostonDOT23

Submit a Speaker Proposal
Register Early for Maximum Savings
Stay up to Date on our 2023 Program
2023 Programs
Download Brochure
View All Sponsors
View Media Partners

September 25

Emerging Immune Modulation Strategies

Strategies for Targeting Kinases

September 26-27

Protein Degraders and Molecular Glues – Part 1

Proteomics-Driven Drug Discovery

Small Molecules Targeting RNA

Small Molecules for Cancer Targets – Part 1

Neurodegeneration Targets

GPCR-Based Drug Discovery

Antibodies Against Membrane Protein Targets – Part 1

AI/ML-Enabled Drug Discovery – Part 1

September 27-28

Protein Degraders and Molecular Glues – Part 2

Genomics-Driven Drug Discovery

Targeting Transcription Factors

Small Molecules for Cancer Targets – Part 2

Fibrosis and Inflammation

Lead Generation Strategies

Antibodies Against Membrane Protein Targets – Part 2

AI/ML-Enabled Drug Discovery – Part 2

CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Investing and Partnering

CHI Divisions

Conferences

Reports & Market Research

Barnett Educational Services

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy